Efficacy and Safety of Leflunomide for Refractory COVID-19: A Pilot Study

Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may persist in patients with coronavirus disease 2019 (COVID-19) despite receiving standard care. Methods: In this pilot study of hospitalized adult patients (≥18 years of age), with radiologically confirmed pneumonia who w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiang, Guo, Haipeng, Li, Yu, Jian, Xiangdong, Hou, Xinguo, Zhong, Ning, Fei, Jianchun, Su, Dezhen, Bian, Zhouyan, Zhang, Yi, Hu, Yingying, Sun, Yan, Yu, Xueyuan, Li, Yuan, Jiang, Bei, Li, Yan, Qin, Fengping, Wu, Yingying, Gao, Yanxia, Hu, Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284962/
https://www.ncbi.nlm.nih.gov/pubmed/34276351
http://dx.doi.org/10.3389/fphar.2021.581833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284962/
https://www.ncbi.nlm.nih.gov/pubmed/34276351
http://dx.doi.org/10.3389/fphar.2021.581833

Ejemplares similares